Advances in the diagnosis and treatment of HBeAg-negative chronic hepatitis B
10.3969/j.issn.1001-5256.2020.07.035
- VernacularTitle:HBeAg阴性慢性乙型肝炎的诊治进展
- Author:
Huaxian CHEN
1
;
Jia WEI
2
Author Information
1. Kunming Medical University, Kunming 650000, China
2. Department of Infectious Diseases and Hepatology, The Fourth Affiliated Hospital of Kunming Medical University, Kunming 650000, China
- Publication Type:Research Article
- Keywords:
hepatitis B, chronic;
hepatitis B e antigens;
diagnosis;
therapeutics
- From:
Journal of Clinical Hepatology
2020;36(7):1612-1614
- CountryChina
- Language:Chinese
-
Abstract:
Chronic hepatitis B (CHB) is one of the most common chronic infectious diseases in China, and the prevalence rate of HBeAg-negative CHB has been increasing year by year, causing serious harm to the security of public health in China. With reference to the pathogenesis, diagnosis, and treatment of HBeAg-negative CHB, this article reviews the clinical research advances in recent years and summarizes the new advances in the diagnosis and treatment of HBeAg-negative CHB.
